Hormone alters male brain networks to enhance sexual and emotional function
New Imperial group aims to grow the number of clinical academic leaders
Imperial celebrates its newest graduates at Commemoration Day 2018
One of the largest teaching and research organisations in the UK, with a reputation for excellence and a vibrant and international working community.
A small clinical trial has shown that a new drug has promise for targeting tumours in patients with an aggressive type of blood cancer.
Imperial scientists have helped unravel the genetic code of tuberculosis (TB), enabling doctors to tailor treatments to each individual patient.
A new study reveals how the global burden of childhood tuberculosis could be reduced by better targeting of high-risk households
Tissues grown in the lab from stem cells may fail to live up their therapeutic promise because the cells choose their own fate.
The expert-led research groups within the Department cover five divisions
Find out more
The Department hosts undergraduate offerings - like the MBBS - as well as a variety of MSc and MRes options.
Find out more
Our research has directly led to far-reaching impacts and benefits being realised on a global scale.
Imperial immunologist recognised by World Economic Forum
16 October 2018
Synthetic biology success as Imperial experts win prestigious award
15 October 2018
12 October 2018
10 October 2018
18 October 2018, 13:30 – 14:30
RNA Interactions and Post-Transcriptional RNA Regulation in Advanced Prostate Cancer